FDA Inspection 770753 — Lonza Biologics, Inc.

Lonza Biologics, Inc. — FEI 3001701602

The FDA completed an inspection of Lonza Biologics, Inc. on Mar 1, 2012 in Hopkinton, MA. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.

Inspection details

Classification
Official Action Indicated (OAI)
End Date
Mar 1, 2012
Fiscal Year
2012
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Hopkinton, MA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.